Rationale for local treatment in the management of metastatic prostate cancer

Giorgio Gandaglia, Nicola Fossati, Paolo Dell'Oglio, Marco Moschini, Vito Cucchiara, Nazareno Suardi, Alexandre Mottrie, Vincenzo Mirone, Francesco Montorsi, Alberto Briganti

Research output: Contribution to journalReview article

Abstract

Purpose of review To evaluate the rationale supporting the role of local treatment in the management of patients with metastatic prostate cancer (PCa). Recent findings Not all patients with metastatic PCa share the same prognosis, in which selected individuals with oligometastatic PCa might benefit from local therapies. These men would harbor a biologically different disease as compared with their counterparts with widespread metastases. Local treatment would eliminate the source of tumor-promoting factors, destroy the origin of metastatic cells, and stop the self-seeding process. Moreover, decreasing tumor burden would eventually allow for an improved response to systemic therapies. Recent clinical studies support an oncologic role of surgery or radiotherapy in metastatic PCa. However, their retrospective nature limits the relevance of these findings. Results of ongoing trials assessing the impact of local treatment in metastatic patients are needed to comprehensively address its role. Summary Preclinical observations provide a rationale for treatment of the primary tumor in selected patients with metastatic PCa. However, available clinical evidence comes from retrospective investigations, and only results of ongoing randomized trials would clarify the role of local treatment in the metastatic setting.

Original languageEnglish
Pages (from-to)266-272
Number of pages7
JournalCurrent Opinion in Supportive and Palliative Care
Volume10
Issue number3
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Prostatic Neoplasms
Therapeutics
Tumor Burden
Neoplasms
Radiotherapy
Neoplasm Metastasis

Keywords

  • local treatment
  • metastatic
  • prostate cancer
  • radical prostatectomy
  • radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)
  • Critical Care and Intensive Care Medicine
  • Oncology(nursing)

Cite this

Rationale for local treatment in the management of metastatic prostate cancer. / Gandaglia, Giorgio; Fossati, Nicola; Dell'Oglio, Paolo; Moschini, Marco; Cucchiara, Vito; Suardi, Nazareno; Mottrie, Alexandre; Mirone, Vincenzo; Montorsi, Francesco; Briganti, Alberto.

In: Current Opinion in Supportive and Palliative Care, Vol. 10, No. 3, 01.09.2016, p. 266-272.

Research output: Contribution to journalReview article

Gandaglia, Giorgio ; Fossati, Nicola ; Dell'Oglio, Paolo ; Moschini, Marco ; Cucchiara, Vito ; Suardi, Nazareno ; Mottrie, Alexandre ; Mirone, Vincenzo ; Montorsi, Francesco ; Briganti, Alberto. / Rationale for local treatment in the management of metastatic prostate cancer. In: Current Opinion in Supportive and Palliative Care. 2016 ; Vol. 10, No. 3. pp. 266-272.
@article{37aebb5e14da40fc9b86a8279ec55186,
title = "Rationale for local treatment in the management of metastatic prostate cancer",
abstract = "Purpose of review To evaluate the rationale supporting the role of local treatment in the management of patients with metastatic prostate cancer (PCa). Recent findings Not all patients with metastatic PCa share the same prognosis, in which selected individuals with oligometastatic PCa might benefit from local therapies. These men would harbor a biologically different disease as compared with their counterparts with widespread metastases. Local treatment would eliminate the source of tumor-promoting factors, destroy the origin of metastatic cells, and stop the self-seeding process. Moreover, decreasing tumor burden would eventually allow for an improved response to systemic therapies. Recent clinical studies support an oncologic role of surgery or radiotherapy in metastatic PCa. However, their retrospective nature limits the relevance of these findings. Results of ongoing trials assessing the impact of local treatment in metastatic patients are needed to comprehensively address its role. Summary Preclinical observations provide a rationale for treatment of the primary tumor in selected patients with metastatic PCa. However, available clinical evidence comes from retrospective investigations, and only results of ongoing randomized trials would clarify the role of local treatment in the metastatic setting.",
keywords = "local treatment, metastatic, prostate cancer, radical prostatectomy, radiotherapy",
author = "Giorgio Gandaglia and Nicola Fossati and Paolo Dell'Oglio and Marco Moschini and Vito Cucchiara and Nazareno Suardi and Alexandre Mottrie and Vincenzo Mirone and Francesco Montorsi and Alberto Briganti",
year = "2016",
month = "9",
day = "1",
doi = "10.1097/SPC.0000000000000218",
language = "English",
volume = "10",
pages = "266--272",
journal = "Current Opinion in Supportive and Palliative Care",
issn = "1751-4258",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Rationale for local treatment in the management of metastatic prostate cancer

AU - Gandaglia, Giorgio

AU - Fossati, Nicola

AU - Dell'Oglio, Paolo

AU - Moschini, Marco

AU - Cucchiara, Vito

AU - Suardi, Nazareno

AU - Mottrie, Alexandre

AU - Mirone, Vincenzo

AU - Montorsi, Francesco

AU - Briganti, Alberto

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Purpose of review To evaluate the rationale supporting the role of local treatment in the management of patients with metastatic prostate cancer (PCa). Recent findings Not all patients with metastatic PCa share the same prognosis, in which selected individuals with oligometastatic PCa might benefit from local therapies. These men would harbor a biologically different disease as compared with their counterparts with widespread metastases. Local treatment would eliminate the source of tumor-promoting factors, destroy the origin of metastatic cells, and stop the self-seeding process. Moreover, decreasing tumor burden would eventually allow for an improved response to systemic therapies. Recent clinical studies support an oncologic role of surgery or radiotherapy in metastatic PCa. However, their retrospective nature limits the relevance of these findings. Results of ongoing trials assessing the impact of local treatment in metastatic patients are needed to comprehensively address its role. Summary Preclinical observations provide a rationale for treatment of the primary tumor in selected patients with metastatic PCa. However, available clinical evidence comes from retrospective investigations, and only results of ongoing randomized trials would clarify the role of local treatment in the metastatic setting.

AB - Purpose of review To evaluate the rationale supporting the role of local treatment in the management of patients with metastatic prostate cancer (PCa). Recent findings Not all patients with metastatic PCa share the same prognosis, in which selected individuals with oligometastatic PCa might benefit from local therapies. These men would harbor a biologically different disease as compared with their counterparts with widespread metastases. Local treatment would eliminate the source of tumor-promoting factors, destroy the origin of metastatic cells, and stop the self-seeding process. Moreover, decreasing tumor burden would eventually allow for an improved response to systemic therapies. Recent clinical studies support an oncologic role of surgery or radiotherapy in metastatic PCa. However, their retrospective nature limits the relevance of these findings. Results of ongoing trials assessing the impact of local treatment in metastatic patients are needed to comprehensively address its role. Summary Preclinical observations provide a rationale for treatment of the primary tumor in selected patients with metastatic PCa. However, available clinical evidence comes from retrospective investigations, and only results of ongoing randomized trials would clarify the role of local treatment in the metastatic setting.

KW - local treatment

KW - metastatic

KW - prostate cancer

KW - radical prostatectomy

KW - radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84981172795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981172795&partnerID=8YFLogxK

U2 - 10.1097/SPC.0000000000000218

DO - 10.1097/SPC.0000000000000218

M3 - Review article

AN - SCOPUS:84981172795

VL - 10

SP - 266

EP - 272

JO - Current Opinion in Supportive and Palliative Care

JF - Current Opinion in Supportive and Palliative Care

SN - 1751-4258

IS - 3

ER -